In line with the mouse experiments, high SERPINF2 expression in leukemia cells was associated with a significant survival extension in patients with B-ALL (Fig. 8C; Supplementary Fig. 20G). Here, SERPINF2 is linked to precursor B-cell acute lymphoblastic leukemia.